Clinical Trial Update: Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study

View source ↗

Summary

Clinical trial update describing a long-term, cohort study of ustekinumab in Crohn's disease and ulcerative colitis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: IBD - Inflammatory Bowel Disease | Status: RECRUITING